Results 161 to 170 of about 191,162 (262)

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation

, 2012
Plamen Kinov1, Mihail Boyanov21Department of Orthopedics and Traumatology, University Hospital Queen Giovanna – ISUL, 2Department of Internal Medicine, Clinic of Endocrinology, University Hospital Alexandrovska, Medical University of Sofia ...
Kinov P, Boyanov M
core  

Comparison of Denosumab and Bisphosphonates for Sarcopenia in Postmenopausal Osteoporosis. [PDF]

J Clin Med
Yetemen SK, Hocaoglu E, Erturk E.
europepmc   +1 more source

Treatment options for postmenopausal osteoporosis

, 2012
Garry M WalshDivision of Applied Medicine, School of Medicine and Dentistry, Institute of Medical Sciences, University of Aberdeen, United KingdomTo serve our readership better, future editions of Therapeutics and Clinical Risk Management will once again
Walsh GM
core  

Postmenopausal Osteoporosis, Endothelial Dysfunction, and Cardiovascular Risk. [PDF]

J Clin Rheumatol
Pickering ME, Heiss C, Morel V, Pickering G, Couderc M, Mathieu S, Malochet-Guinamand S, Durif J, Sapin V, Pereira B, Tournadre A, Chapurlat R.   +11 more
europepmc   +1 more source

Evidence mapping and meta-analysis of traditional Chinese medicine for postmenopausal osteoporosis. [PDF]

Medicine (Baltimore)
Xi X, Yan X, Fan J, Zhang Y, Wang Z.
europepmc   +1 more source

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

, 2017
Aska Toda, Kenjiro Sawada, Akihiko Yoshimura, Erika Nakatsuka, Hiromasa Kuroda, Katsumi Kozasa, Mayuko Miyamoto, Kae Hashimoto, Seiji Mabuchi, Tadashi Kimura Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita ...
Yoshimura A, Kozasa K, Sawada K, Mabuchi S, Kimura T, Kuroda H, Miyamoto M, Nakatsuka E, Toda A, Hashimoto K   +9 more
core  

Romosozumab in severe postmenopausal osteoporosis-real-world data from 192 women. [PDF]

Osteoporos Int
Dehne N, von Brackel FN, Günzl C, Barvencik F, Oheim R.   +4 more
europepmc   +1 more source

Nationwide trends and demographic projections of hospitalisations for vertebral fractures and postmenopausal osteoporosis in Germany: a 24-year registry-based study. [PDF]

Arch Osteoporos
Anees H, Qadourah K, Georgievski G, Heiss C, El Khassawna T.   +4 more
europepmc   +1 more source

The FGF23/α-Klotho Axis in Postmenopausal Osteoporosis: Associations with Bone Mineral Density and Diagnostic Discrimination. [PDF]

J Clin Med
Karalok MH, Misirlioglu NF, Akin OD, Uzun H.   +3 more
europepmc   +1 more source

The estrogen-ferroptosis axis in postmenopausal osteoporosis, osteoarthritis, and intervertebral disc degeneration: shared mechanisms and emerging evidence. [PDF]

Front Immunol
Zheng K, Zhang P, Wang S, Wang L, Zheng X, Nik Ramli NN, Tan J.   +6 more
europepmc   +1 more source